| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 164.99B | 185.15B | 202.52B | 180.32B | 294.67B |
| Gross Profit | 26.64B | 32.76B | 41.15B | 41.73B | 71.05B |
| EBITDA | 20.78B | 27.80B | 42.56B | 37.73B | 64.40B |
| Net Income | 12.36B | 15.64B | 25.61B | 23.26B | 40.16B |
Balance Sheet | |||||
| Total Assets | 916.09B | 908.63B | 923.60B | 1.03T | 1.06T |
| Cash, Cash Equivalents and Short-Term Investments | 103.67B | 124.17B | 105.63B | 123.85B | 160.19B |
| Total Debt | 247.81B | 242.55B | 258.72B | 317.04B | 308.49B |
| Total Liabilities | 496.01B | 506.80B | 530.69B | 606.45B | 627.29B |
| Stockholders Equity | 388.11B | 380.61B | 373.02B | 397.99B | 420.27B |
Cash Flow | |||||
| Free Cash Flow | 9.73B | 46.26B | 35.07B | -12.64B | 16.70B |
| Operating Cash Flow | 9.95B | 46.45B | 35.28B | -11.90B | 16.97B |
| Investing Cash Flow | -7.37B | 1.84B | -4.77B | -8.14B | -14.47B |
| Financing Cash Flow | -22.49B | -29.80B | -35.02B | -2.07B | 14.43B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$396.71B | 6.70 | 3.55% | 3.89% | 4.66% | 26.27% | |
74 Outperform | HK$169.88B | 12.36 | 2.75% | 4.33% | 27.01% | -20.16% | |
67 Neutral | HK$118.29B | 15.34 | 2.20% | 5.62% | 30.32% | -1.37% | |
66 Neutral | HK$229.62B | 3.64 | 8.80% | 5.18% | 2.11% | -0.55% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
62 Neutral | HK$56.57B | 52.44 | 0.65% | 3.96% | -23.93% | -89.99% | |
54 Neutral | HK$135.50B | 7.48 | 3.54% | 4.54% | -9.39% | -19.08% |